Pionyr Immunotherapeutics' Series A Round

Pionyr Immunotherapeutics raised a round of funding on January 04, 2017.

Pionyr, formerly Precision Immune, is developing cancer immunotherapies that target the tumor microenvironment to enhance the body's antitumor immunity. The company is exploiting target discovery and …

Articles about Pionyr Immunotherapeutics' Series A Round: